Cargando…

Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK Signaling

Mechanisms that regulate the transition of metastases from clinically undetectable and dormant to progressively growing are the least understood aspects of cancer biology. Here, we show that a large (∼70%) reduction in the urokinase plasminogen activator receptor (uPAR) level in human carcinoma HEp3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghiso, Julio A. Aguirre, Kovalski, Katherine, Ossowski, Liliana
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1999
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2164973/ https://www.ncbi.nlm.nih.gov/pubmed/10508858

Ejemplares similares

Reduction in Surface Urokinase Receptor Forces Malignant Cells into a Protracted State of Dormancy
por: Yu, W., et al.
Publicado: (1997)

Urokinase Receptor uPAR Downregulation in Neuroblastoma Leads to Dormancy, Chemoresistance and Metastasis
por: Shmakova, Anna A., et al.
Publicado: (2022)

Prostate Cancer Dormancy and Reactivation in Bone Marrow
por: Singh, Deepak K., et al.
Publicado: (2021)

Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
por: Kim, Ryung S., et al.
Publicado: (2012)

A Role for Caveolin and the Urokinase Receptor in Integrin-mediated Adhesion and Signaling
por: Wei, Ying, et al.
Publicado: (1999)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

In silico docking of urokinase plasminogen activator and integrins
por: Degryse, Bernard, et al.
Publicado: (2008)

Regulation of α5β1 integrin conformation and function by urokinase receptor binding
por: Wei, Ying, et al.
Publicado: (2005)

Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR–β1 integrin complex in colon cancer cells
por: Ahmed, N, et al.
Publicado: (2003)

Involvement of the Soluble Urokinase Receptor in Chondrosarcoma Cell Mobilization
por: Bifulco, Katia, et al.
Publicado: (2011)

Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow
por: Yumoto, Kenji, et al.
Publicado: (2016)

Urokinase Receptor (CD87) Regulates Leukocyte Recruitment via β(2) Integrins In Vivo
por: May, Andreas E., et al.
Publicado: (1998)

The Urokinase Receptor Takes Control of Cell Migration by Recruiting Integrins and FPR1 on the Cell Surface
por: Gorrasi, Anna, et al.
Publicado: (2014)

A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy
por: Di Martino, Julie S., et al.
Publicado: (2022)

5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling
por: Singh, Deepak K., et al.
Publicado: (2023)

Involvement of redox signalling in tumour cell dormancy and metastasis
por: Puente-Cobacho, Beatriz, et al.
Publicado: (2023)

Thrombosis recanalization by paeoniflorin through the upregulation of urokinase-type plasminogen activator via the MAPK signaling pathway
por: YE, SONGSHAN, et al.
Publicado: (2016)

Urokinase plasminogen activator receptor, beta 2-integrins, and Src- kinases within a single receptor complex of human monocytes
Publicado: (1995)

On the theory of tumor self-seeding: implications for metastasis progression in humans
por: Aguirre-Ghiso, Julio A
Publicado: (2010)

An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy
por: Khalil, Bassem D., et al.
Publicado: (2021)

Ascites induces modulation of α6β1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma
por: Ahmed, N, et al.
Publicado: (2005)

Downregulation of PARVA promotes metastasis by modulating integrin-linked kinase activity and regulating MAPK/ERK and MLC2 signaling in prostate cancer
por: Huang, Cong, et al.
Publicado: (2021)

Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways
por: Chéry, Lisly, et al.
Publicado: (2014)

Data on the regulation of moesin and merlin by the urokinase receptor (uPAR): Model explaining distal activation of integrins by uPAR
por: Degryse, Bernard, et al.
Publicado: (2017)

Primary tumor associated macrophages activate programs of invasion and dormancy in disseminating tumor cells
por: Borriello, Lucia, et al.
Publicado: (2022)

The Urokinase/Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF Receptors
por: Rossi, Francesca Wanda, et al.
Publicado: (2016)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
por: Zhu, Ran, et al.
Publicado: (2022)

Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View
por: Alfano, Daniela, et al.
Publicado: (2022)

Integrin signaling downregulates filopodia during muscle–tendon attachment
por: Richier, Benjamin, et al.
Publicado: (2018)

Downregulation of CXCR4 in Metastasized Breast Cancer Cells and Implication in Their Dormancy
por: Nobutani, Kentaro, et al.
Publicado: (2015)

Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis
por: Lee, Ji-Hye, et al.
Publicado: (2014)

NR2F1 controls tumor cell dormancy via SOX9 and RARβ driven quiescence programs
por: Sosa, Maria Soledad, et al.
Publicado: (2015)

Non-canonical integrin signaling activates EGFR and RAS-MAPK-ERK signaling in small cell lung cancer
por: Rubio, Karla, et al.
Publicado: (2023)

Downregulation of uPAR promotes urokinase translocation into the nucleus and epithelial to mesenchymal transition in neuroblastoma
por: Semina, Ekaterina V., et al.
Publicado: (2020)

Role of Urokinase Receptor in Tumor Progression and Development
por: Noh, Hyangsoon, et al.
Publicado: (2013)

Urokinase receptor and resistance to targeted anticancer agents
por: Gonias, Steven L., et al.
Publicado: (2015)

The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review
por: Tucker, Torry A., et al.
Publicado: (2021)

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.
por: Cantero, D., et al.
Publicado: (1997)

Origin and interpretation of cancer transcriptome profiling: the essential role of the stroma in determining prognosis and drug resistance
por: Goossens, Nicolas, et al.
Publicado: (2015)

Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment
por: Selleri, Carmine, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l9j4jqmgont20aoutp5jbq95q9